MoneyWorks4Me

Zydus Lifesciences informs about press release

22 Jul 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 22, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Bhava™ (Bevacizumab biosimilar) to treat various cancers’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1745.85
Dr. Reddys Labs. 1234.40
Cipla 1328.70
Lupin 1951.30
Zydus Lifesciences 1121.90
View more..